Literature DB >> 23929778

Crystal structure of sialylated IgG Fc: implications for the mechanism of intravenous immunoglobulin therapy.

Max Crispin1, Xiaojie Yu, Thomas A Bowden.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23929778      PMCID: PMC3780870          DOI: 10.1073/pnas.1310657110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  5 in total

1.  Identification of a receptor required for the anti-inflammatory activity of IVIG.

Authors:  Robert M Anthony; Fredrik Wermeling; Mikael C I Karlsson; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-26       Impact factor: 11.205

2.  Dissecting the molecular mechanism of IVIg therapy: the interaction between serum IgG and DC-SIGN is independent of antibody glycoform or Fc domain.

Authors:  Xiaojie Yu; Snezana Vasiljevic; Daniel A Mitchell; Max Crispin; Christopher N Scanlan
Journal:  J Mol Biol       Date:  2013-02-13       Impact factor: 5.469

3.  General mechanism for modulating immunoglobulin effector function.

Authors:  Peter Sondermann; Andrew Pincetic; Jad Maamary; Katja Lammens; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-22       Impact factor: 11.205

4.  NMR characterization of immunoglobulin G Fc glycan motion on enzymatic sialylation.

Authors:  Adam W Barb; Lu Meng; Zhongwei Gao; Roy W Johnson; Kelley W Moremen; James H Prestegard
Journal:  Biochemistry       Date:  2012-05-22       Impact factor: 3.162

5.  Chemical and structural analysis of an antibody folding intermediate trapped during glycan biosynthesis.

Authors:  Thomas A Bowden; Kavitha Baruah; Charlotte H Coles; David J Harvey; Xiaojie Yu; Byeong-Doo Song; David I Stuart; A Radu Aricescu; Christopher N Scanlan; E Yvonne Jones; Max Crispin
Journal:  J Am Chem Soc       Date:  2012-10-15       Impact factor: 16.383

  5 in total
  47 in total

1.  Reply to Crispin et al.: Molecular model that accounts for the biological and physical properties of sialylated Fc.

Authors:  Peter Sondermann; Andrew Pincetic; Jad Maamary; Katja Lammens; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-17       Impact factor: 11.205

2.  Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils.

Authors:  Ian K Campbell; Sylvia Miescher; Donald R Branch; Patrick J Mott; Alan H Lazarus; Dongji Han; Eugene Maraskovsky; Adrian W Zuercher; Anton Neschadim; Danila Leontyev; Brent S McKenzie; Fabian Käsermann
Journal:  J Immunol       Date:  2014-04-23       Impact factor: 5.422

3.  Processing of complex N-glycans in IgG Fc-region is affected by core fucosylation.

Authors:  Alexandra Castilho; Clemens Gruber; Andreas Thader; Chris Oostenbrink; Maria Pechlaner; Herta Steinkellner; Friedrich Altmann
Journal:  MAbs       Date:  2015       Impact factor: 5.857

4.  The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc γ receptor.

Authors:  Ganesh P Subedi; Adam W Barb
Journal:  MAbs       Date:  2016-08-05       Impact factor: 5.857

5.  Highly parallel characterization of IgG Fc binding interactions.

Authors:  Austin W Boesch; Eric P Brown; Hao D Cheng; Maame Ofua Ofori; Erica Normandin; Peter A Nigrovic; Galit Alter; Margaret E Ackerman
Journal:  MAbs       Date:  2014 Jul-Aug       Impact factor: 5.857

Review 6.  Targeting B cells and autoantibodies in the therapy of autoimmune diseases.

Authors:  Daniela Kao; Anja Lux; Inessa Schwab; Falk Nimmerjahn
Journal:  Semin Immunopathol       Date:  2014-04-29       Impact factor: 9.623

Review 7.  Analytical comparability study of recombinant monoclonal antibody therapeutics.

Authors:  Alexandre Ambrogelly; Stephen Gozo; Amit Katiyar; Shara Dellatore; Yune Kune; Ram Bhat; Joanne Sun; Ning Li; Dongdong Wang; Christine Nowak; Alyssa Neill; Gomathinayagam Ponniah; Cory King; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-03-20       Impact factor: 5.857

8.  Immunoglobulin G1 Fc domain motions: implications for Fc engineering.

Authors:  Martin Frank; Ross C Walker; William N Lanzilotta; James H Prestegard; Adam W Barb
Journal:  J Mol Biol       Date:  2014-02-09       Impact factor: 5.469

Review 9.  Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?

Authors:  Michaela Seeling; Christin Brückner; Falk Nimmerjahn
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

10.  Structural plasticity of the Semliki Forest virus glycome upon interspecies transmission.

Authors:  Max Crispin; David J Harvey; David Bitto; Camille Bonomelli; Matthew Edgeworth; James H Scrivens; Juha T Huiskonen; Thomas A Bowden
Journal:  J Proteome Res       Date:  2014-02-10       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.